Suppr超能文献

评估肾移植前心脏 PET 时冠状动脉钙评分与持续性甲状旁腺功能亢进的相关性:一项回顾性研究。

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persistent Hyperparathyroidism: A Retrospective Study.

机构信息

Division of Nephrology, Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

出版信息

Ann Transplant. 2024 Apr 2;29:e943532. doi: 10.12659/AOT.943532.

Abstract

BACKGROUND Secondary hyperparathyroidism and coronary calcifications are common complications in chronic kidney disease. However, the relation between coronary calcium score (CCS) and persistent hyperparathyroidism (pHPT) after kidney transplantation (KT) remains unknown. MATERIAL AND METHODS This was a single-center retrospective study of KT candidates from January 2017 to May 2020. We collected patients' demographics, cardiovascular (CV) risk factors, and the findings of pre-KT CV imaging. We also collected parathyroid hormone (PTH) values before KT, at 1-6 months, 6-12 months, and 12-24 months after KT. We defined pHPT as PTH ≥25.5 pmol/L after 12 months post-KT. RESULTS A total of 111 KT recipients (KTRs) with a mean age of 50.4 years were included, of which 62.2% were men and 77.5% were living-donor KTRs. Dialysis modality used before KT was peritoneal dialysis in 9.9% and hemodialysis in 82.9%. Dialysis vintage was 3±2.9 years. The prevalence of pHPT was 24.3% (n=27), and the prevalence of severe coronary calcifications (CCS >400 Agatston units) was 19.8% (n=22). PTH values at baseline, 1-6 months, 6-12 months, and 12-24 months were not different among between CCS >400 or CCS <400 groups. However, pHPT after KT was significantly more prevalent in KTRs with severe CCS (37% vs 14.3%, p=0.014). Severe CCS was associated with less improvement of PTH values after KT (r=0.288, p=0.020). Otherwise, the findings of cardiac PET and coronary angiogram were not significantly different between pHPT and non-pHPT patients. CCS >400 was independently associated with pHPT after transplant (aOR=18.8, P=0.012). CONCLUSIONS Severe CCS on pre-KT cardiac assessment is associated with pHPT after KT.

摘要

背景

继发性甲状旁腺功能亢进症和冠状动脉钙化是慢性肾脏病的常见并发症。然而,移植后甲状旁腺激素持续升高(pHPT)与肾移植后(KT)冠状动脉钙评分(CCS)之间的关系尚不清楚。

材料和方法

这是一项单中心回顾性研究,纳入了 2017 年 1 月至 2020 年 5 月期间的 KT 候选者。我们收集了患者的人口统计学、心血管(CV)危险因素以及预 KT CV 影像学检查结果。我们还收集了 KT 前、KT 后 1-6 个月、6-12 个月和 12-24 个月的甲状旁腺激素(PTH)值。我们将 KT 后 12 个月 PTH≥25.5 pmol/L 定义为 pHPT。

结果

共纳入 111 例 KT 受者(KTR),平均年龄为 50.4 岁,其中 62.2%为男性,77.5%为活体供者 KTR。KT 前的透析方式为腹膜透析 9.9%,血液透析 82.9%。透析龄为 3±2.9 年。pHPT 的患病率为 24.3%(n=27),严重冠状动脉钙化(CCS>400 单位)的患病率为 19.8%(n=22)。CCS>400 组和 CCS<400 组之间,基线、1-6 个月、6-12 个月和 12-24 个月的 PTH 值无差异。然而,严重 CCS 患者的 pHPT 发生率明显更高(37% vs 14.3%,p=0.014)。KT 后,严重 CCS 与 PTH 值改善不明显相关(r=0.288,p=0.020)。此外,pHPT 患者和非 pHPT 患者的心脏 PET 和冠状动脉造影结果无显著差异。CCS>400 与移植后 pHPT 独立相关(优势比=18.8,P=0.012)。

结论

KT 前心脏评估中严重的 CCS 与 KT 后 pHPT 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/135e/10998472/3defa797f2a4/anntransplant-29-e943532-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验